IONS
Ionis Pharmaceuticals, Inc.Healthcare$74.79
◆ Neutral
Mkt Cap: $12.35B|Float: 163.9M|SI: 8.5%|DTC: 6.2
Data as of market close Apr 2, 2026
IV Rank
51
IV Pctl
67%
HV 20d
2938.0%
52W Range
$24-$87
ATR(14)
$2.37
Exp. Move
±4.5%
P/C Ratio
0.96
Earnings
May 6
GEX Negative
DEX Long
Net Call Premium
IV Moderate
Exp. Move Wide
IONS Key Options Data
- IV Rank
- 51.2%
- Total GEX
- $-0.00B
- Total DEX
- $1.8M
- Max Pain
- $75.00
- Expected Move
- ±4.5%
- Put/Call OI
- 0.96
- Net Premium
- $2.6M
- Spot Price
- $74.79
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$3.33 | ±4.5% | $71.47 | $78.12 |
| 2026-05-15 | 43 | ±$4.70 | ±6.3% | $70.09 | $79.49 |
| 2026-07-17 | 106 | ±$14.55 | ±19.4% | $60.24 | $89.34 |
| 2026-08-21 | 141 | ±$8.30 | ±11.1% | $66.49 | $83.09 |
| 2026-09-18 | 169 | ±$9.90 | ±13.2% | $64.89 | $84.69 |
| 2026-10-16 | 197 | ±$9.50 | ±12.7% | $65.29 | $84.29 |
Explore IONS options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.